DE224851C - - Google Patents
Info
- Publication number
- DE224851C DE224851C DENDAT224851D DE224851DA DE224851C DE 224851 C DE224851 C DE 224851C DE NDAT224851 D DENDAT224851 D DE NDAT224851D DE 224851D A DE224851D A DE 224851DA DE 224851 C DE224851 C DE 224851C
- Authority
- DE
- Germany
- Prior art keywords
- swine fever
- animals
- serum
- organs
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001465754 Metazoa Species 0.000 claims description 16
- 241000282898 Sus scrofa Species 0.000 claims description 14
- 210000002966 serum Anatomy 0.000 claims description 14
- 206010037660 Pyrexia Diseases 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 10
- 210000000056 organ Anatomy 0.000 claims description 10
- 241000700605 Viruses Species 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 229960005486 vaccine Drugs 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000000740 bleeding effect Effects 0.000 claims description 3
- 210000003205 muscle Anatomy 0.000 claims description 3
- 210000000683 abdominal cavity Anatomy 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 210000000115 thoracic cavity Anatomy 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000002070 germicidal effect Effects 0.000 claims 1
- 239000000284 extract Substances 0.000 description 8
- 241000282887 Suidae Species 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000002255 vaccination Methods 0.000 description 7
- 230000001681 protective effect Effects 0.000 description 5
- 241000283086 Equidae Species 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000710777 Classical swine fever virus Species 0.000 description 3
- 206010035148 Plague Diseases 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000031295 Animal disease Diseases 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- -1 Chloro- Chemical class 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241001331845 Equus asinus x caballus Species 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 229940124452 immunizing agent Drugs 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/187—Hog cholera virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE224851C true DE224851C (enrdf_load_stackoverflow) |
Family
ID=485551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT224851D Active DE224851C (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE224851C (enrdf_load_stackoverflow) |
-
0
- DE DENDAT224851D patent/DE224851C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0304786A2 (de) | Intranasale Impfung von Pferden mit inaktivierten Mikroorganismen oder antigenem Material | |
| DE2725204A1 (de) | Immunitaets-stimulierendes medikament und verfahren zu seiner herstellung | |
| DE2444299A1 (de) | Impfstoffe gegen katzen-leukaemie | |
| DE2816942C2 (de) | Impfstoff gegen Rhinitis atrophicans beim Schwein | |
| DE224851C (enrdf_load_stackoverflow) | ||
| DE2212277C3 (de) | Verfahren zur Herstellung einer Totvaccine gegen infektiöse atrophische Rhinitis der Schweine | |
| AT48339B (de) | Verfahren zur Herstellung eines Impfstoffes gegen Schweinepest. | |
| EP0445710A1 (de) | Verwendung von Zink-Calciumhydroxid, Lecithin und PAO zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen | |
| DE60213785T2 (de) | Saponin inaktivierte mykoplasma impfstoffe | |
| DE833673C (de) | Verfahren zur Herstellung einer Schweinecholera-Lymphe | |
| DE69231724T2 (de) | Fischimpfstoff gegen infektion mit aeromonas salmonicida | |
| DE1492243C3 (de) | Injizierbare Impfstoffe | |
| DE2262427A1 (de) | Immunostimulierendes mittel und verfahren zu dessen herstellung | |
| DE191752C (enrdf_load_stackoverflow) | ||
| DE2700338C2 (de) | Parenteral injizierbarer Impfstoff für Schweine gegen Infektionen von Bordetella bronchiseptica sowie Verfahren zum Herstellen dieses Impfstoffes | |
| DE940315C (de) | Verfahren zur Herstellung von Lymphe gegen Schweinepest | |
| Kielstein | Systematic control of dermatophytosis profunda of cattle in the former GDR | |
| DE602004004768T2 (de) | Subkutan verabreichte impfstoffzusammensetzungen auf gangliosidbasis | |
| DE859055C (de) | Verfahren zur Herstellung von Seren und Impfstoffen | |
| DE1467849A1 (de) | Verfahren zur Herstellung von Vakzinen | |
| DE141888C (enrdf_load_stackoverflow) | ||
| Baljer et al. | Wirksamkeit und Unschädlichkeit von Pasteurella multocida‐Vaccinen aus inaktivierten Keimen nach subkutaner, oraler und intranasaler Applikation bei der Maus | |
| DE945948C (de) | Verfahren zur Herstellung eines Poliomyelitis-Vaccine | |
| DE1492179A1 (de) | Verfahren zur Herstellung von perkutan wirksamen Zubereitungen von Impfstoffen | |
| DE229131C (enrdf_load_stackoverflow) |